Anti-O-linked N-acetylglucosamine (O-GlcNAc) [14D9.D4]
RECENTLY UPDATED
RECENTLY UPDATED
Invented at University of Georgia
- Datasheet
- References (2)
- Inventor Info
Info
Catalogue Number | 153888 |
Applications
RECENTLY UPDATED
|
ELISA WB |
Antigen/Gene or Protein Targets
RECENTLY UPDATED |
O-linked N-acetylglucosamine |
Synonyms
RECENTLY UPDATED |
O-GlcNAc |
Reactivity
RECENTLY UPDATED
|
Mammals |
Relevance
RECENTLY UPDATED |
The study of O-GlcNAc, a ubiquitous translation and transcription regulator which is found in a wide variety of proteins, is of great relevance to multiple chronic human and veterinary diseases. These include diabetes (and its effects in the heart, kidneys and eyes), cardiovascular disease, neurodegenerative disorders involving both plaque and tangle formation, inflammatory processes, liver disease, fibrosis, metabolic disorders and cancer. There is fast growing collection of evidence that O-GlcNAcylation plays a pivotal role in epigenetics. |
Host
RECENTLY UPDATED
|
Mouse |
Immunogen
RECENTLY UPDATED |
Synthetic peptide O-GlcNAc |
Subclass
RECENTLY UPDATED |
IgG2a |
Notes
RECENTLY UPDATED |
This a 23 Mab panel was developed specifically to study the diverse roles of O-GlcNAc and that can be employed for detection, isolation, and site localization. For details on antigen strategy, please consult: Chin Fen Teo, et al., Nat Chem Biol. 2010 May; 6(5): 338-343. doi:10.1038/nchembio.338. |
Research Area
RECENTLY UPDATED |
Cell Signaling & Signal Transduction, Metabolism, Cancer, Epigenetics & Nuclear Signalling, Gene Expression, Neurobiology |
References: 2 entries
RECENTLY UPDATED
RECENTLY UPDATED
References: 2 entries
RECENTLY UPDATED
RECENTLY UPDATED